Health‐related quality of life and psychological well‐being in men with benign prostatic hyperplasia: An integrative review

Pinto, Julian Dong Oh; He, Hong; Chan, Sally Wai‐Chi; Wang, Wenru

doi:10.1111/jjns.12115

Cited by 20 publications

(20 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Symptoms of BPH, unlike other chronic diseases such as hypertension and diabetes, are often perceived as less serious. Some may simply consider it an inconvenience in daily life, while others do not think treatment is necessary and that the condition it will naturally improve [ 41 ]. We can judge that as delay occurs in the treatment of BPH for this reason, the patient’s subjective health state lowers and HRQOL consequently reduces.…”

Section: Discussionmentioning

confidence: 99%

Quality of Life in Older Adults with Benign Prostatic Hyperplasia

2020

View full text Add to dashboard Cite

The purpose of this study is to identify factors that affect health-related quality of life (HRQOL) of older patients with Benign Prostatic Hyperplasia (BPH) and suggest ways to improve the same. Through this, we will improve the self-management practice of patients and promote the treatment of BPH in older patients. The 2015 Korea Health Panel Survey data were used in this study. A total of 422 BPH patients aged 65 or older were included. Logistic regression analysis was conducted to identify factors affecting the HRQOL of older patients with BPH. General characteristics of factors affecting older patients with BPH included income level and type of insurance. In addition, among medical-related characteristics and health behavior factors, subjective health status, unmet medical care needs, moderate physical activity, sitting time, and drinking influenced the HRQOL. Therefore, in order to improve the HRQOL of adult patients with BPH, it is necessary to improve medical accessibility by strengthening primary care. In addition, it is necessary to increase the amount of activity in daily life through healthcare medical devices.

show abstract

Section: Discussionmentioning

confidence: 99%

Quality of Life in Older Adults with Benign Prostatic Hyperplasia

2020

View full text Add to dashboard Cite

show abstract

“…However, the health-related quality of life of BPH patients is considered as poor, and their psychological well-being is severely affected. For instance, postvoid residual urine, lower urinary tract symptoms, anxiety and depression are identified to be significant predictive factors of the health-related quality of life of patients with enlarged prostate (10) . Thus, we suggested that men with enlarged prostate may not wear during 6 months something on the body that is helpless.…”

Section: Discussionmentioning

confidence: 99%

Thermobalancing conservative treatment for moderate-to-low-degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement

Allen

Aghajanyan

2016

Cogent Medicine

View full text Add to dashboard Cite

Background: The prostate undergoes gradually growth throughout men's lives, resulting development of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH). The aim of this review was to determine whether Thermobalancing could be used for conservative treatment of LUTS/BPH. Methods and Results: Men older than 55 with LUTS derived to BPH used Thermobalancing therapy enabled by therapeutic device as mono therapy. The main group consisted of 124 patients with the prostate volume (PV) up to 60 ml, however, there were also men with the prostate volume (PV) over 60 ml that were studied separately. Before and after 6 months Thermobalancing the International Prostate Symptom Score (IPSS) lessened (P <0.001), quality of life (QoL) index improved, ultrasound PV reduced (P <0.001) and uroflowmetry maximum flow rate (Q max ) increased (P <0.001). The dynamics of the same measurements in the watchful waiting or active surveillance control-group have shown negative outcomes. Discussion and Conclusions:The observed positive effect of therapeutic device for BPH has allowed us to recommend this side-effect free therapy in watchful waiting or active surveillance approach. Therefore, Thermobalancing can be used as safe physiotherapeutic solution for men with enlarged prostate in order to reduce LUTS.

show abstract

“…The presence of a "placebo" or "sham" group as a control could provide more statistical rigor with respect to results. However, most men with CP/CPPS have psychological problems, they largely do not respond to medical interventions, and pain syndrome is associated with a decrease in QoL [46,47]. Similar problems are observed in men with BPH suffering from depression and anxiety, their health-related QoL is considered poor, and their psychological well-being is seriously affected [48,49].…”

Section: Discussionmentioning

confidence: 95%

Treatment of Kidney Stone Disease, Benign Prostatic Hyperplasia and Chronic Prostatitis with Thermobalancing Therapy should be listed in the Guidance for Health Professionals

2018

ARC Journal of Urology

View full text Add to dashboard Cite

The prevalence of kidney stone disease, chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH) increases around the world. Long-term medications and surgical procedures for these non-life-threatening chronic conditions can develop serious side effects and complications. At the same time, Thermobalancing therapy (TT) with Dr Allen's therapeutic Device (DATD) has shown its high effectiveness in the treatment of chronic internal diseases. Discussion at many international conferences in 2017-2018 was aimed at treating various chronic non-malignant diseases with the help of Thermobalancing therapy, such as BPH, CP/CPPS, kidney stones and cardiovascular diseases. In the conferences were presented cases of TT with DATD of patients with kidney stone disease that confirm the ability of DATD to dissolve any type and size of kidney stone; discussed the outcomes from the clinical trials of TT in 124 men with BPH and 45 patients with CP/CPPS, before and after 6-month period they used DATD. The assured results of the cases and clinical trials reveal that TT with DATD treats the cause of kidney stone disease, CP/CPPS and BPH. Implementation of this therapy is needed today, as it helps patients avoid long-term drugs and surgical procedures, including extracorporeal shock wave lithotripsy (ESWL) with their risks and complications. In addition, it is a cost-effective solution. Therefore, conference participants proposed that TT with DATD should be included in the Guidance for health professionals.

show abstract

Health‐related quality of life and psychological well‐being in men with benign prostatic hyperplasia: An integrative review

Cited by 20 publications

References 40 publications

Quality of Life in Older Adults with Benign Prostatic Hyperplasia

Quality of Life in Older Adults with Benign Prostatic Hyperplasia

Thermobalancing conservative treatment for moderate-to-low-degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement

Treatment of Kidney Stone Disease, Benign Prostatic Hyperplasia and Chronic Prostatitis with Thermobalancing Therapy should be listed in the Guidance for Health Professionals

Contact Info

Product

Resources

About